Caselli RJ - Search Results

1

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D. Reiman EM, et al. Among authors: caselli rj. N Engl J Med. 1996 Mar 21;334(12):752-8. doi: 10.1056/NEJM199603213341202. N Engl J Med. 1996. PMID: 8592548

2

Progressive apraxia in clinically discordant monozygotic twins.

Caselli RJ, Reiman EM, Timmann D, Stelmach GE, Lawson MA, Osborne D, Moore SB, Cevette MJ. Caselli RJ, et al. Arch Neurol. 1995 Oct;52(10):1004-10. doi: 10.1001/archneur.1995.00540340096018. Arch Neurol. 1995. PMID: 7575217

3

Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease.

Reiman EM, Uecker A, Caselli RJ, Lewis S, Bandy D, de Leon MJ, De Santi S, Convit A, Osborne D, Weaver A, Thibodeau SN. Reiman EM, et al. Among authors: caselli rj. Ann Neurol. 1998 Aug;44(2):288-91. doi: 10.1002/ana.410440226. Ann Neurol. 1998. PMID: 9708558

4

From slowly progressive amnesic syndrome to rapidly progressive Alzheimer disease.

Caselli RJ, Couce ME, Osborne D, Deen HG, Parisi JP. Caselli RJ, et al. Alzheimer Dis Assoc Disord. 1998 Sep;12(3):251-3. Alzheimer Dis Assoc Disord. 1998. PMID: 9772031

5

Alzheimer's disease.

Reiman EM, Caselli RJ. Reiman EM, et al. Among authors: caselli rj. Maturitas. 1999 Mar 15;31(3):185-200. doi: 10.1016/s0378-5122(98)00110-8. Maturitas. 1999. PMID: 10340278 Review.

6

Preclinical memory decline in cognitively normal apolipoprotein E-epsilon4 homozygotes.

Caselli RJ, Graff-Radford NR, Reiman EM, Weaver A, Osborne D, Lucas J, Uecker A, Thibodeau SN. Caselli RJ, et al. Neurology. 1999 Jul 13;53(1):201-7. doi: 10.1212/wnl.53.1.201. Neurology. 1999. PMID: 10408560

7

Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease.

Reiman EM, Caselli RJ, Chen K, Alexander GE, Bandy D, Frost J. Reiman EM, et al. Among authors: caselli rj. Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3334-9. doi: 10.1073/pnas.061509598. Proc Natl Acad Sci U S A. 2001. PMID: 11248079 Free PMC article.

8

Preclinical cognitive decline in late middle-aged asymptomatic apolipoprotein E-e4/4 homozygotes: a replication study.

Caselli RJ, Osborne D, Reiman EM, Hentz JG, Barbieri CJ, Saunders AM, Hardy J, Graff-Radford NR, Hall GR, Alexander GE. Caselli RJ, et al. J Neurol Sci. 2001 Aug 15;189(1-2):93-8. doi: 10.1016/s0022-510x(01)00577-9. J Neurol Sci. 2001. PMID: 11535238

9

Apolipoprotein E and intellectual achievement.

Caselli RJ, Hentz JG, Osborne D, Graff-Radford NR, Barbieri CJ, Alexander GE, Hall GR, Reiman EM, Hardy J, Saunders AM. Caselli RJ, et al. J Am Geriatr Soc. 2002 Jan;50(1):49-54. doi: 10.1046/j.1532-5415.2002.50007.x. J Am Geriatr Soc. 2002. PMID: 12028246

10

Apolipoprotein E epsilon 4 affects new learning in cognitively normal individuals at risk for Alzheimer's disease.

Baxter LC, Caselli RJ, Johnson SC, Reiman E, Osborne D. Baxter LC, et al. Among authors: caselli rj. Neurobiol Aging. 2003 Nov;24(7):947-52. doi: 10.1016/s0197-4580(03)00006-x. Neurobiol Aging. 2003. PMID: 12928055 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results